Peptic ulcer disease among dyspeptic patients at endoscopy unit, University of Gondar hospital, Northwest Ethiopia
Background Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least one month. Globally, peptic ulcer disease occurs in 3.5–32% of patients with dyspepsia. Helicobacter pylori ( H. pylori ) infection and non-steroidal an...
Saved in:
| Published in: | BMC gastroenterology Vol. 22; no. 1; pp. 164 - 7 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
BioMed Central
05.04.2022
BioMed Central Ltd Springer Nature B.V BMC |
| Subjects: | |
| ISSN: | 1471-230X, 1471-230X |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least one month. Globally, peptic ulcer disease occurs in 3.5–32% of patients with dyspepsia.
Helicobacter pylori
(
H. pylori
) infection and non-steroidal anti-inflammatory drugs/aspirin use are the widely known risk factors for peptic ulcer disease. There was no recent document on
H. pylori
infection rate among patients with peptic ulcer disease in Ethiopia. This study aimed to determine magnitude and associated factors of peptic ulcer disease among dyspeptic patients in Northwest Ethiopia.
Methods
An institutional-based cross sectional study was conducted at the University of Gondar hospital, Northwest Ethiopia. A convenience sampling method was used to recruit 218 study subjects. A pre-designed semi-structured questionnaire was used to extract clinical information. Olympus flexible fiber-optic endoscope (Olympus, GIF-E 600, Olympus Corp., Hamburg, Germany) was used to confirm the presence of peptic ulcer disease. Diagnosis of active
H. pylori
infection was made using the fecal
H. pylori
Antigen 25 T Card Test (Anamol Lab., Pvt. Ltd., Palghar, India). The Data were entered into EPI Info version 4.6.0.2, and then exported to SPSS version 20 for analysis. Explanatory variables associated with peptic ulcer disease were analyzed by applying logistic regression model.
P
value < 0.05 was used to declare significant association.
Result
A total of 218 dyspeptic patients who underwent upper gastrointestinal endoscopic evaluations were included in the study. The mean (+ SD) age of patients was 42 ± 16.4 years. Forty nine percent (95% CI 42.4–56.2) of dyspeptic patients had active
H. pylori
infection. Peptic ulcer disease was diagnosed in 35% (95% CI 31.4–39.2) of patients with dyspepsia.
H. pylori
infection (AOR = 6.298, 95% CI 2.965–13.378,
P
value < 0.001) and NSAIDs/ASA use (AOR = 6.252, 95% CI 2.925–13.362,
P
value < 0.001) were identified as risk factors for peptic ulcer disease.
Conclusion
Medical treatment of peptic ulcer disease should target treatment of
H. pylori
infection and cautious use of non-steroidal anti-inflammatory drugs/aspirin. |
|---|---|
| AbstractList | Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least one month. Globally, peptic ulcer disease occurs in 3.5-32% of patients with dyspepsia. Helicobacter pylori (H. pylori) infection and non-steroidal anti-inflammatory drugs/aspirin use are the widely known risk factors for peptic ulcer disease. There was no recent document on H. pylori infection rate among patients with peptic ulcer disease in Ethiopia. This study aimed to determine magnitude and associated factors of peptic ulcer disease among dyspeptic patients in Northwest Ethiopia.BACKGROUNDDyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least one month. Globally, peptic ulcer disease occurs in 3.5-32% of patients with dyspepsia. Helicobacter pylori (H. pylori) infection and non-steroidal anti-inflammatory drugs/aspirin use are the widely known risk factors for peptic ulcer disease. There was no recent document on H. pylori infection rate among patients with peptic ulcer disease in Ethiopia. This study aimed to determine magnitude and associated factors of peptic ulcer disease among dyspeptic patients in Northwest Ethiopia.An institutional-based cross sectional study was conducted at the University of Gondar hospital, Northwest Ethiopia. A convenience sampling method was used to recruit 218 study subjects. A pre-designed semi-structured questionnaire was used to extract clinical information. Olympus flexible fiber-optic endoscope (Olympus, GIF-E 600, Olympus Corp., Hamburg, Germany) was used to confirm the presence of peptic ulcer disease. Diagnosis of active H. pylori infection was made using the fecal H. pylori Antigen 25 T Card Test (Anamol Lab., Pvt. Ltd., Palghar, India). The Data were entered into EPI Info version 4.6.0.2, and then exported to SPSS version 20 for analysis. Explanatory variables associated with peptic ulcer disease were analyzed by applying logistic regression model. P value < 0.05 was used to declare significant association.METHODSAn institutional-based cross sectional study was conducted at the University of Gondar hospital, Northwest Ethiopia. A convenience sampling method was used to recruit 218 study subjects. A pre-designed semi-structured questionnaire was used to extract clinical information. Olympus flexible fiber-optic endoscope (Olympus, GIF-E 600, Olympus Corp., Hamburg, Germany) was used to confirm the presence of peptic ulcer disease. Diagnosis of active H. pylori infection was made using the fecal H. pylori Antigen 25 T Card Test (Anamol Lab., Pvt. Ltd., Palghar, India). The Data were entered into EPI Info version 4.6.0.2, and then exported to SPSS version 20 for analysis. Explanatory variables associated with peptic ulcer disease were analyzed by applying logistic regression model. P value < 0.05 was used to declare significant association.A total of 218 dyspeptic patients who underwent upper gastrointestinal endoscopic evaluations were included in the study. The mean (+ SD) age of patients was 42 ± 16.4 years. Forty nine percent (95% CI 42.4-56.2) of dyspeptic patients had active H. pylori infection. Peptic ulcer disease was diagnosed in 35% (95% CI 31.4-39.2) of patients with dyspepsia. H. pylori infection (AOR = 6.298, 95% CI 2.965-13.378, P value < 0.001) and NSAIDs/ASA use (AOR = 6.252, 95% CI 2.925-13.362, P value < 0.001) were identified as risk factors for peptic ulcer disease.RESULTA total of 218 dyspeptic patients who underwent upper gastrointestinal endoscopic evaluations were included in the study. The mean (+ SD) age of patients was 42 ± 16.4 years. Forty nine percent (95% CI 42.4-56.2) of dyspeptic patients had active H. pylori infection. Peptic ulcer disease was diagnosed in 35% (95% CI 31.4-39.2) of patients with dyspepsia. H. pylori infection (AOR = 6.298, 95% CI 2.965-13.378, P value < 0.001) and NSAIDs/ASA use (AOR = 6.252, 95% CI 2.925-13.362, P value < 0.001) were identified as risk factors for peptic ulcer disease.Medical treatment of peptic ulcer disease should target treatment of H. pylori infection and cautious use of non-steroidal anti-inflammatory drugs/aspirin.CONCLUSIONMedical treatment of peptic ulcer disease should target treatment of H. pylori infection and cautious use of non-steroidal anti-inflammatory drugs/aspirin. Background Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least one month. Globally, peptic ulcer disease occurs in 3.5-32% of patients with dyspepsia. Helicobacter pylori (H. pylori) infection and non-steroidal anti-inflammatory drugs/aspirin use are the widely known risk factors for peptic ulcer disease. There was no recent document on H. pylori infection rate among patients with peptic ulcer disease in Ethiopia. This study aimed to determine magnitude and associated factors of peptic ulcer disease among dyspeptic patients in Northwest Ethiopia. Methods An institutional-based cross sectional study was conducted at the University of Gondar hospital, Northwest Ethiopia. A convenience sampling method was used to recruit 218 study subjects. A pre-designed semi-structured questionnaire was used to extract clinical information. Olympus flexible fiber-optic endoscope (Olympus, GIF-E 600, Olympus Corp., Hamburg, Germany) was used to confirm the presence of peptic ulcer disease. Diagnosis of active H. pylori infection was made using the fecal H. pylori Antigen 25 T Card Test (Anamol Lab., Pvt. Ltd., Palghar, India). The Data were entered into EPI Info version 4.6.0.2, and then exported to SPSS version 20 for analysis. Explanatory variables associated with peptic ulcer disease were analyzed by applying logistic regression model. P value < 0.05 was used to declare significant association. Result A total of 218 dyspeptic patients who underwent upper gastrointestinal endoscopic evaluations were included in the study. The mean (+ SD) age of patients was 42 [+ or -] 16.4 years. Forty nine percent (95% CI 42.4-56.2) of dyspeptic patients had active H. pylori infection. Peptic ulcer disease was diagnosed in 35% (95% CI 31.4-39.2) of patients with dyspepsia. H. pylori infection (AOR = 6.298, 95% CI 2.965-13.378, P value < 0.001) and NSAIDs/ASA use (AOR = 6.252, 95% CI 2.925-13.362, P value < 0.001) were identified as risk factors for peptic ulcer disease. Conclusion Medical treatment of peptic ulcer disease should target treatment of H. pylori infection and cautious use of non-steroidal anti-inflammatory drugs/aspirin. Keywords: Dyspepsia, Peptic ulcer disease, H. pylori, NSAIDs, Northwest Ethiopia Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least one month. Globally, peptic ulcer disease occurs in 3.5-32% of patients with dyspepsia. Helicobacter pylori (H. pylori) infection and non-steroidal anti-inflammatory drugs/aspirin use are the widely known risk factors for peptic ulcer disease. There was no recent document on H. pylori infection rate among patients with peptic ulcer disease in Ethiopia. This study aimed to determine magnitude and associated factors of peptic ulcer disease among dyspeptic patients in Northwest Ethiopia. An institutional-based cross sectional study was conducted at the University of Gondar hospital, Northwest Ethiopia. A convenience sampling method was used to recruit 218 study subjects. A pre-designed semi-structured questionnaire was used to extract clinical information. Olympus flexible fiber-optic endoscope (Olympus, GIF-E 600, Olympus Corp., Hamburg, Germany) was used to confirm the presence of peptic ulcer disease. Diagnosis of active H. pylori infection was made using the fecal H. pylori Antigen 25 T Card Test (Anamol Lab., Pvt. Ltd., Palghar, India). The Data were entered into EPI Info version 4.6.0.2, and then exported to SPSS version 20 for analysis. Explanatory variables associated with peptic ulcer disease were analyzed by applying logistic regression model. P value < 0.05 was used to declare significant association. A total of 218 dyspeptic patients who underwent upper gastrointestinal endoscopic evaluations were included in the study. The mean (+ SD) age of patients was 42 [+ or -] 16.4 years. Forty nine percent (95% CI 42.4-56.2) of dyspeptic patients had active H. pylori infection. Peptic ulcer disease was diagnosed in 35% (95% CI 31.4-39.2) of patients with dyspepsia. H. pylori infection (AOR = 6.298, 95% CI 2.965-13.378, P value < 0.001) and NSAIDs/ASA use (AOR = 6.252, 95% CI 2.925-13.362, P value < 0.001) were identified as risk factors for peptic ulcer disease. Medical treatment of peptic ulcer disease should target treatment of H. pylori infection and cautious use of non-steroidal anti-inflammatory drugs/aspirin. Background Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least one month. Globally, peptic ulcer disease occurs in 3.5–32% of patients with dyspepsia. Helicobacter pylori ( H. pylori ) infection and non-steroidal anti-inflammatory drugs/aspirin use are the widely known risk factors for peptic ulcer disease. There was no recent document on H. pylori infection rate among patients with peptic ulcer disease in Ethiopia. This study aimed to determine magnitude and associated factors of peptic ulcer disease among dyspeptic patients in Northwest Ethiopia. Methods An institutional-based cross sectional study was conducted at the University of Gondar hospital, Northwest Ethiopia. A convenience sampling method was used to recruit 218 study subjects. A pre-designed semi-structured questionnaire was used to extract clinical information. Olympus flexible fiber-optic endoscope (Olympus, GIF-E 600, Olympus Corp., Hamburg, Germany) was used to confirm the presence of peptic ulcer disease. Diagnosis of active H. pylori infection was made using the fecal H. pylori Antigen 25 T Card Test (Anamol Lab., Pvt. Ltd., Palghar, India). The Data were entered into EPI Info version 4.6.0.2, and then exported to SPSS version 20 for analysis. Explanatory variables associated with peptic ulcer disease were analyzed by applying logistic regression model. P value < 0.05 was used to declare significant association. Result A total of 218 dyspeptic patients who underwent upper gastrointestinal endoscopic evaluations were included in the study. The mean (+ SD) age of patients was 42 ± 16.4 years. Forty nine percent (95% CI 42.4–56.2) of dyspeptic patients had active H. pylori infection. Peptic ulcer disease was diagnosed in 35% (95% CI 31.4–39.2) of patients with dyspepsia. H. pylori infection (AOR = 6.298, 95% CI 2.965–13.378, P value < 0.001) and NSAIDs/ASA use (AOR = 6.252, 95% CI 2.925–13.362, P value < 0.001) were identified as risk factors for peptic ulcer disease. Conclusion Medical treatment of peptic ulcer disease should target treatment of H. pylori infection and cautious use of non-steroidal anti-inflammatory drugs/aspirin. Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least one month. Globally, peptic ulcer disease occurs in 3.5-32% of patients with dyspepsia. Helicobacter pylori (H. pylori) infection and non-steroidal anti-inflammatory drugs/aspirin use are the widely known risk factors for peptic ulcer disease. There was no recent document on H. pylori infection rate among patients with peptic ulcer disease in Ethiopia. This study aimed to determine magnitude and associated factors of peptic ulcer disease among dyspeptic patients in Northwest Ethiopia. An institutional-based cross sectional study was conducted at the University of Gondar hospital, Northwest Ethiopia. A convenience sampling method was used to recruit 218 study subjects. A pre-designed semi-structured questionnaire was used to extract clinical information. Olympus flexible fiber-optic endoscope (Olympus, GIF-E 600, Olympus Corp., Hamburg, Germany) was used to confirm the presence of peptic ulcer disease. Diagnosis of active H. pylori infection was made using the fecal H. pylori Antigen 25 T Card Test (Anamol Lab., Pvt. Ltd., Palghar, India). The Data were entered into EPI Info version 4.6.0.2, and then exported to SPSS version 20 for analysis. Explanatory variables associated with peptic ulcer disease were analyzed by applying logistic regression model. P value < 0.05 was used to declare significant association. A total of 218 dyspeptic patients who underwent upper gastrointestinal endoscopic evaluations were included in the study. The mean (+ SD) age of patients was 42 ± 16.4 years. Forty nine percent (95% CI 42.4-56.2) of dyspeptic patients had active H. pylori infection. Peptic ulcer disease was diagnosed in 35% (95% CI 31.4-39.2) of patients with dyspepsia. H. pylori infection (AOR = 6.298, 95% CI 2.965-13.378, P value < 0.001) and NSAIDs/ASA use (AOR = 6.252, 95% CI 2.925-13.362, P value < 0.001) were identified as risk factors for peptic ulcer disease. Medical treatment of peptic ulcer disease should target treatment of H. pylori infection and cautious use of non-steroidal anti-inflammatory drugs/aspirin. Background Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least one month. Globally, peptic ulcer disease occurs in 3.5–32% of patients with dyspepsia. Helicobacter pylori (H. pylori) infection and non-steroidal anti-inflammatory drugs/aspirin use are the widely known risk factors for peptic ulcer disease. There was no recent document on H. pylori infection rate among patients with peptic ulcer disease in Ethiopia. This study aimed to determine magnitude and associated factors of peptic ulcer disease among dyspeptic patients in Northwest Ethiopia. Methods An institutional-based cross sectional study was conducted at the University of Gondar hospital, Northwest Ethiopia. A convenience sampling method was used to recruit 218 study subjects. A pre-designed semi-structured questionnaire was used to extract clinical information. Olympus flexible fiber-optic endoscope (Olympus, GIF-E 600, Olympus Corp., Hamburg, Germany) was used to confirm the presence of peptic ulcer disease. Diagnosis of active H. pylori infection was made using the fecal H. pylori Antigen 25 T Card Test (Anamol Lab., Pvt. Ltd., Palghar, India). The Data were entered into EPI Info version 4.6.0.2, and then exported to SPSS version 20 for analysis. Explanatory variables associated with peptic ulcer disease were analyzed by applying logistic regression model. P value < 0.05 was used to declare significant association. Result A total of 218 dyspeptic patients who underwent upper gastrointestinal endoscopic evaluations were included in the study. The mean (+ SD) age of patients was 42 ± 16.4 years. Forty nine percent (95% CI 42.4–56.2) of dyspeptic patients had active H. pylori infection. Peptic ulcer disease was diagnosed in 35% (95% CI 31.4–39.2) of patients with dyspepsia. H. pylori infection (AOR = 6.298, 95% CI 2.965–13.378, P value < 0.001) and NSAIDs/ASA use (AOR = 6.252, 95% CI 2.925–13.362, P value < 0.001) were identified as risk factors for peptic ulcer disease. Conclusion Medical treatment of peptic ulcer disease should target treatment of H. pylori infection and cautious use of non-steroidal anti-inflammatory drugs/aspirin. Abstract Background Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least one month. Globally, peptic ulcer disease occurs in 3.5–32% of patients with dyspepsia. Helicobacter pylori (H. pylori) infection and non-steroidal anti-inflammatory drugs/aspirin use are the widely known risk factors for peptic ulcer disease. There was no recent document on H. pylori infection rate among patients with peptic ulcer disease in Ethiopia. This study aimed to determine magnitude and associated factors of peptic ulcer disease among dyspeptic patients in Northwest Ethiopia. Methods An institutional-based cross sectional study was conducted at the University of Gondar hospital, Northwest Ethiopia. A convenience sampling method was used to recruit 218 study subjects. A pre-designed semi-structured questionnaire was used to extract clinical information. Olympus flexible fiber-optic endoscope (Olympus, GIF-E 600, Olympus Corp., Hamburg, Germany) was used to confirm the presence of peptic ulcer disease. Diagnosis of active H. pylori infection was made using the fecal H. pylori Antigen 25 T Card Test (Anamol Lab., Pvt. Ltd., Palghar, India). The Data were entered into EPI Info version 4.6.0.2, and then exported to SPSS version 20 for analysis. Explanatory variables associated with peptic ulcer disease were analyzed by applying logistic regression model. P value < 0.05 was used to declare significant association. Result A total of 218 dyspeptic patients who underwent upper gastrointestinal endoscopic evaluations were included in the study. The mean (+ SD) age of patients was 42 ± 16.4 years. Forty nine percent (95% CI 42.4–56.2) of dyspeptic patients had active H. pylori infection. Peptic ulcer disease was diagnosed in 35% (95% CI 31.4–39.2) of patients with dyspepsia. H. pylori infection (AOR = 6.298, 95% CI 2.965–13.378, P value < 0.001) and NSAIDs/ASA use (AOR = 6.252, 95% CI 2.925–13.362, P value < 0.001) were identified as risk factors for peptic ulcer disease. Conclusion Medical treatment of peptic ulcer disease should target treatment of H. pylori infection and cautious use of non-steroidal anti-inflammatory drugs/aspirin. |
| ArticleNumber | 164 |
| Audience | Academic |
| Author | Assefa, Belete Abay, Zenahebezu Molla, Ayenew Tesfaye, Tsebaot Abebe, Alula Tadesse, Melaku Tadesse, Abilo |
| Author_xml | – sequence: 1 givenname: Belete surname: Assefa fullname: Assefa, Belete organization: Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar – sequence: 2 givenname: Abilo surname: Tadesse fullname: Tadesse, Abilo email: abilo.tadesse@yahoo.com organization: Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar – sequence: 3 givenname: Zenahebezu surname: Abay fullname: Abay, Zenahebezu organization: Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar – sequence: 4 givenname: Alula surname: Abebe fullname: Abebe, Alula organization: Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar – sequence: 5 givenname: Tsebaot surname: Tesfaye fullname: Tesfaye, Tsebaot organization: Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar – sequence: 6 givenname: Melaku surname: Tadesse fullname: Tadesse, Melaku organization: Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, University of Gondar – sequence: 7 givenname: Ayenew surname: Molla fullname: Molla, Ayenew organization: Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35382748$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UltrFDEYHaRiL_oHfJCAL33o1Fwml3kRSqm1UNQHC76FTCbZzTKbjEmmsv_ebKe23SIlhIQv55x83-EcVns-eFNV7xE8RUiwTwlhwVkNMd7uhtbsVXWAGo5qTOCvvSf3_eowpRWEiAtM3lT7hBKBeSMOqvjDjNlpMA3aRNC7ZFQyQK2DX4B-k8b5dVTZGZ8TUBkY34ekw7gBk3f5BNx4d2ticnkDggWXwfcqgmVIo8tqOAHfQszLPyZlcJGXLoxOva1eWzUk8-7-PKpuvlz8PP9aX3-_vDo_u641gzzXAipI2r7F5dJTYwVsrMFQEcKZQIRDQ4y1VpHOWtp2UFDRYKsgazGjHDfkqLqadfugVnKMbq3iRgbl5F0hxIVUsUw3GMkLl7Wd7XTHGkxhR7qWWdJ0jMLSwFbr86w1Tt3a9LqYEdWwI7r74t1SLsKtFK2AnPEicHwvEMPvqdgh1y5pMwzKmzAliVnDGS2NwwL9-Ay6ClP0xaqCohgSzEnziFqoMoDzNpR_9VZUnrG2pRRRhgrq9D-osnqzdrrEybpS3yF8eDrow4T_ElMAeAboGFKKxj5AEJTbWMo5lrJEUt7FUrJCEs9IuqQju7A1yw0vU8lMTeUfvzDx0Y0XWH8BV1L1xg |
| CitedBy_id | crossref_primary_10_31146_1682_8658_ecg_207_11_102_109 crossref_primary_10_1038_s41598_025_00097_0 crossref_primary_10_1186_s12876_025_03906_y crossref_primary_10_31146_1682_8658_ecg_211_3_46_52 crossref_primary_10_1186_s13099_024_00618_8 crossref_primary_10_70749_ijbr_v3i4_961 crossref_primary_10_1177_00099228241248717 crossref_primary_10_1371_journal_pone_0319854 crossref_primary_10_1186_s13568_024_01783_4 crossref_primary_10_1007_s11033_024_09329_4 |
| Cites_doi | 10.1155/2009/181059 10.1136/tc.9.2.155 10.1038/ajg.2017.154 10.1056/NEJMcp1001110 10.1186/s12876-018-0927-3 10.1053/j.gastro.2017.04.022 10.1016/j.amjmed.2018.12.009 10.18203/2394-6040.ijcmph20183869 10.1038/ajg.2016.563 10.4314/thrb.v16i1.3 10.1111/j.1365-2036.2005.02554.x 10.4314/ahs.v16i2.32 10.5946/ce.2016.129 10.1016/S0140-6736(09)60938-7 10.1155/2021/9646932 10.31557/APJCP.2018.19.12.3565 10.1053/j.gastro.2016.02.011 10.1371/journal.pone.0256393 10.1155/2018/9064952 10.3748/wjg.v25.i26.3344 10.1371/journal.pone.0238868 10.1136/pmj.77.904.82 10.1093/aje/kwh005 10.4236/ojmm.2020.104020 10.14309/ajg.0000000000000517 10.1179/000349804225003190 10.3390/jcm10163473 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022 2022. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7QR 7T5 7X7 7XB 88E 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH H94 K9. M0S M1P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12876-022-02245-6 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Statistics |
| EISSN | 1471-230X |
| EndPage | 7 |
| ExternalDocumentID | oai_doaj_org_article_758469bfbcb64250b3b96f34b6509284 PMC8980767 A699551561 35382748 10_1186_s12876_022_02245_6 |
| Genre | Journal Article |
| GeographicLocations | Ethiopia United States--US |
| GeographicLocations_xml | – name: Ethiopia – name: United States--US |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM 7QP 7QR 7T5 7XB 8FD 8FK AZQEC DWQXO FR3 H94 K9. P64 PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c607t-80a039d9280ad5ef804fe20a337681370e3efffa3bff59b085842fa0692657243 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 11 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000778832900002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-230X |
| IngestDate | Fri Oct 03 12:51:43 EDT 2025 Tue Nov 04 01:44:38 EST 2025 Sun Aug 24 04:02:01 EDT 2025 Mon Oct 06 18:40:24 EDT 2025 Tue Nov 11 10:39:47 EST 2025 Tue Nov 04 17:23:09 EST 2025 Thu Jan 02 22:54:51 EST 2025 Tue Nov 18 21:11:08 EST 2025 Sat Nov 29 06:24:13 EST 2025 Sat Sep 06 07:35:50 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Northwest Ethiopia Peptic ulcer disease Dyspepsia NSAIDs H. pylori |
| Language | English |
| License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c607t-80a039d9280ad5ef804fe20a337681370e3efffa3bff59b085842fa0692657243 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/758469bfbcb64250b3b96f34b6509284 |
| PMID | 35382748 |
| PQID | 2652032734 |
| PQPubID | 44673 |
| PageCount | 7 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_758469bfbcb64250b3b96f34b6509284 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8980767 proquest_miscellaneous_2647656570 proquest_journals_2652032734 gale_infotracmisc_A699551561 gale_infotracacademiconefile_A699551561 pubmed_primary_35382748 crossref_primary_10_1186_s12876_022_02245_6 crossref_citationtrail_10_1186_s12876_022_02245_6 springer_journals_10_1186_s12876_022_02245_6 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-04-05 |
| PublicationDateYYYYMMDD | 2022-04-05 |
| PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-05 day: 05 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC gastroenterology |
| PublicationTitleAbbrev | BMC Gastroenterol |
| PublicationTitleAlternate | BMC Gastroenterol |
| PublicationYear | 2022 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | I Mladenova (2245_CR12) 2021; 10 JK Hooi (2245_CR31) 2017; 153 WD Chey (2245_CR26) 2017; 112 D Asrat (2245_CR8) 2004; 98 SP Lee (2245_CR16) 2017; 50 2245_CR29 AC Jemilohun (2245_CR21) 2010; 6 P Malfertheiner (2245_CR9) 2009; 374 A Melese (2245_CR30) 2019; 19 RA Hussein (2245_CR25) 2021; 16 CN Mwangi (2245_CR23) 2020; 10 M Laugesen (2245_CR28) 2000; 9 MJ Groenen (2245_CR3) 2009; 23 N Abdu (2245_CR27) 2020; 15 EJ Frech (2245_CR15) 2009; 5 DT Quach (2245_CR19) 2018; 19 SM Ayana (2245_CR22) 2014; 16 LA Garcia Rodriguez (2245_CR14) 2004; 159 R Russell (2245_CR13) 2001; 77 AM Asali (2245_CR17) 2018; 5 TN Archampong (2245_CR6) 2019; 25 A Sonnenberg (2245_CR18) 2020; 115 B Xia (2245_CR5) 2005; 22 A Latif (2245_CR4) 2021; 13 RT Kavitt (2245_CR10) 2019; 132 KE McColl (2245_CR11) 2010; 362 A Talebi Bezmin Abadi (2245_CR24) 2018; 2018 PM Moayyedi (2245_CR1) 2017; 112 V Stanghellini (2245_CR2) 2016; 150 OG Okoye (2245_CR7) 2021; 2021 TN Archampong (2245_CR20) 2016; 16 |
| References_xml | – volume: 23 start-page: 604 issue: 9 year: 2009 ident: 2245_CR3 publication-title: Can J Gastroenterol doi: 10.1155/2009/181059 – volume: 9 start-page: 155 issue: 2 year: 2000 ident: 2245_CR28 publication-title: Tob Control doi: 10.1136/tc.9.2.155 – volume: 112 start-page: 988 issue: 7 year: 2017 ident: 2245_CR1 publication-title: Off J Am Coll Gastroenterol: ACG. doi: 10.1038/ajg.2017.154 – volume: 362 start-page: 1597 year: 2010 ident: 2245_CR11 publication-title: N Engl J Med doi: 10.1056/NEJMcp1001110 – volume: 19 start-page: 1 issue: 1 year: 2019 ident: 2245_CR30 publication-title: BMC Gastroenterol doi: 10.1186/s12876-018-0927-3 – volume: 153 start-page: 420 issue: 2 year: 2017 ident: 2245_CR31 publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.04.022 – volume: 132 start-page: 447 issue: 4 year: 2019 ident: 2245_CR10 publication-title: Am J Med doi: 10.1016/j.amjmed.2018.12.009 – volume: 5 start-page: 4617 issue: 10 year: 2018 ident: 2245_CR17 publication-title: Int J Community Med Public Health doi: 10.18203/2394-6040.ijcmph20183869 – volume: 5 start-page: 65 year: 2009 ident: 2245_CR15 publication-title: Ther Clin Risk Manag – volume: 112 start-page: 212 issue: 2 year: 2017 ident: 2245_CR26 publication-title: Off J Am Coll of Gastroenterol: ACG. doi: 10.1038/ajg.2016.563 – volume: 16 start-page: 16 issue: 1 year: 2014 ident: 2245_CR22 publication-title: Tanzan J Health Res doi: 10.4314/thrb.v16i1.3 – ident: 2245_CR29 – volume: 6 start-page: 18 issue: 1 year: 2010 ident: 2245_CR21 publication-title: Pan Afr Med J. – volume: 22 start-page: 243 issue: 3 year: 2005 ident: 2245_CR5 publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2005.02554.x – volume: 16 start-page: 611 issue: 2 year: 2016 ident: 2245_CR20 publication-title: African Health Sci doi: 10.4314/ahs.v16i2.32 – volume: 50 start-page: 578 issue: 6 year: 2017 ident: 2245_CR16 publication-title: Clin Endosc doi: 10.5946/ce.2016.129 – volume: 374 start-page: 1449 issue: 9699 year: 2009 ident: 2245_CR9 publication-title: Lancet doi: 10.1016/S0140-6736(09)60938-7 – volume: 2021 start-page: 1 year: 2021 ident: 2245_CR7 publication-title: Gastroenterol Res Pract. doi: 10.1155/2021/9646932 – volume: 19 start-page: 3565 issue: 12 year: 2018 ident: 2245_CR19 publication-title: Asian Pac J Cancer Prev: APJCP doi: 10.31557/APJCP.2018.19.12.3565 – volume: 150 start-page: 1380 issue: 6 year: 2016 ident: 2245_CR2 publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.02.011 – volume: 16 start-page: e0256393 issue: 8 year: 2021 ident: 2245_CR25 publication-title: PLoS ONE doi: 10.1371/journal.pone.0256393 – volume: 2018 start-page: 1 year: 2018 ident: 2245_CR24 publication-title: J Pathog doi: 10.1155/2018/9064952 – volume: 25 start-page: 3344 issue: 26 year: 2019 ident: 2245_CR6 publication-title: World J Gastroenterol doi: 10.3748/wjg.v25.i26.3344 – volume: 15 start-page: e0238868 issue: 10 year: 2020 ident: 2245_CR27 publication-title: PLoS ONE. doi: 10.1371/journal.pone.0238868 – volume: 77 start-page: 82 issue: 904 year: 2001 ident: 2245_CR13 publication-title: Postgrad Med J doi: 10.1136/pmj.77.904.82 – volume: 159 start-page: 23 issue: 1 year: 2004 ident: 2245_CR14 publication-title: Am J Epidemiol doi: 10.1093/aje/kwh005 – volume: 10 start-page: 233 issue: 04 year: 2020 ident: 2245_CR23 publication-title: Open J Med Microbiol doi: 10.4236/ojmm.2020.104020 – volume: 115 start-page: 244 issue: 2 year: 2020 ident: 2245_CR18 publication-title: Off J Am Coll Gastroenterol: ACG. doi: 10.14309/ajg.0000000000000517 – volume: 98 start-page: 181 issue: 2 year: 2004 ident: 2245_CR8 publication-title: Ann Trop Med Parasitol doi: 10.1179/000349804225003190 – volume: 13 start-page: e15115 issue: 5 year: 2021 ident: 2245_CR4 publication-title: Cureus. – volume: 10 start-page: 3473 issue: 16 year: 2021 ident: 2245_CR12 publication-title: J Clin Med doi: 10.3390/jcm10163473 |
| SSID | ssj0017823 |
| Score | 2.3618033 |
| Snippet | Background
Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least one month.... Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least one month. Globally,... Background Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least one month.... Abstract Background Dyspepsia is a common complaint in upper gastrointestinal disorders. It is described as predominant epigastric pain lasting for at least... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 164 |
| SubjectTerms | Adult Alcohol Antibodies Antigens Aspirin Cancer Complications and side effects Consent Cross-Sectional Studies Diagnosis Diagnostic tests Disease Dyspepsia Dyspepsia - complications Endoscopes Endoscopic surgery Endoscopy Endoscopy, Gastrointestinal Ethiopia - epidemiology Feces Gastroenterology Gastrointestinal diseases Gastrointestinal system H. pylori Helicobacter Infections - complications Helicobacter Infections - diagnosis Helicobacter Infections - epidemiology Helicobacter pylori Hepatology Hospitals Humans Infections Inflammation Information processing Internal Medicine Medical treatment Medicine Medicine & Public Health Middle Aged Nonsteroidal anti-inflammatory drugs Northwest Ethiopia NSAIDs Patients Peptic ulcer Peptic Ulcer - complications Peptic ulcer disease Peptic ulcers Population Prevalence Risk factors Sample size Smoking Sociodemographics Statistics Surgeons Ulcers Variables |
| SummonAdditionalLinks | – databaseName: Publicly Available Content Database dbid: PIMPY link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZgixAX3o9AQUZC4sBGm9qOHydUEAUOrfYAUjlZthO3K1XJkuwi9d_jcby7pIieOESKYkfK2PNyZuYbhN5I4SWVxEF1O8kZqercGs9z74ijUoiK-yo2mxAnJ_L0VM1TeXSf0io3OjEq6gHtGfK2gxKeVa2DP-Yzwkto_S0oe7_8mUMPKYi1poYaN9EeAG_JCdqbfz2e_9hGFYI1pJvCGclnfdDNAlJwCVyszPnIOEUM_7819R-m6moa5ZVYajRRR_f-L3H30d3kquLDgbceoBt18xDdPk7B-Eeom0NGjMPrC1d3OEV6cOxehKvLfjmMJuDWHpsVrpuqhTKYS7wOmmSKd1khuPX4cws_NfB56mQyxTGmBFAOGLLy2-XCPEbfjz59-_glTy0ccscLsQr2zxRUVYqEm6qsvSyYr0lhaNBr8oCKoqa1995Q632pbPD_JCPeFFyFRRCE0Sdo0rRN_QxhJoNzWiljARNfUqMM5ZYFb0iYcGy1RYYONnunXcI3hzYbFzqecyTXw37rsNc67rfmGXq3fWc5oHtcO_sDsMR2JiBzxwdtd6aToGsBHp2y3jobjnZlYalV3FNmAaow-AIZegsMpUF_hM9zJpVBBCIBiUsfcqWCFxvc2gztj2YGuXfj4Q0v6aR3er1jnQy93g7Dm5BL19TtGuYwwSHaHZbs6cDBW5JosH9EMJkhMeLtEc3jkWZxHlHJpZKF4CJD040U7D7r32v6_HoqXqA7JMony4tyH01W3bp-iW65X6tF371K8v0bexVdjA priority: 102 providerName: ProQuest – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELagIMQL9xEoyEhIPLARqe34eCyIwgtVxaW-WbYT05WqZLXZReq_Z8brbEk5JHhYKVrbSjyZy5mZbwh5rlXUXLOA1e2sFKxpS--iLGNggWulGhmb1GxCHR7q42NzlIvChjHbfQxJJk2dxFrLVwNoUoUJswx_oi7lZXIFzJ1Gcfz46es2dgA2j4_lMb9dNzFBCan_V338k0G6mCx5IWKaDNHBzf_bwi1yIzuedH_DKbfJpba7Q659yKH1u2R5hPktga5PQ7ukOW5DUy8i2pwNi81ohmEdqFvRtmt6LGo5o2vQCzN6nuNB-0jf9fiJgp7kviQzmiJECMxAMce-X8zdPfLl4O3nN-_L3JChDLJSK7BmruKmMQwumrqNuhKxZZXjoKX0HldVy9sYo-M-xtp48Oa0YNFV0jBZKyb4fbLT9V37kFChwdVsjPOIcK-5M45LL8C3UQ4Oob4qyN74jmzIaOXYNOPUplOLlnZDTAuEtImYVhbk5XbNYoPV8dfZr_HVb2ciznb6o19-s1lsrUL_zPjog4eDWl157o2MXHgEHgTLXpAXyDgWtQE8XnC5qAE2ibhadl8aAz4pOKkF2Z3MBCkO0-GR9WzWIoMFqmGDe8XhPs-2w7gSM-O6tl_jHKEkxq6BZA82nLrdEgdrxpTQBVETHp7seTrSzU8Sxrg2ulJSFWQ2cvL5Y_2Zpo_-bfpjcp0lYRBlVe-SndVy3T4hV8P31XxYPk1S_QNL-UbN priority: 102 providerName: Springer Nature |
| Title | Peptic ulcer disease among dyspeptic patients at endoscopy unit, University of Gondar hospital, Northwest Ethiopia |
| URI | https://link.springer.com/article/10.1186/s12876-022-02245-6 https://www.ncbi.nlm.nih.gov/pubmed/35382748 https://www.proquest.com/docview/2652032734 https://www.proquest.com/docview/2647656570 https://pubmed.ncbi.nlm.nih.gov/PMC8980767 https://doaj.org/article/758469bfbcb64250b3b96f34b6509284 |
| Volume | 22 |
| WOSCitedRecordID | wos000778832900002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1471-230X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017823 issn: 1471-230X databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: Directory of Open Access Journals customDbUrl: eissn: 1471-230X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017823 issn: 1471-230X databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-230X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017823 issn: 1471-230X databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1471-230X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017823 issn: 1471-230X databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1471-230X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017823 issn: 1471-230X databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1471-230X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017823 issn: 1471-230X databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1471-230X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017823 issn: 1471-230X databaseCode: RSV dateStart: 20011201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagIMQF8SZQKiMhcWCjunHix7FFLXDoalUeWk6WndjqSlWy2gdS_z0zjnfbFAEXDomUtaPY43l5Z_wNIW-VDIqrosbT7UVeFo3PnQ0iD3VRcyVlI0ITi03I8VhNp3pyrdQX5oT18MA94fYlWkjtgqsduMoVc9xpEXjpEPoNdCtqX_B6NpupFD8Au8c3R2SU2F-CFpaYbFvgVVa5GJihiNb_u06-ZpRuJkzeiJpGY3TykDxIXiQ97Ef_iNzy7WNy7zTFyZ-QxQSTVWq6vqj9gqYgDI2FhWhzuZz3rQlTdUntivq26fCEyiVdg5CP6FXCBu0C_djh_w30PBUZGdEY7kGUBYoJ8918Zp-SbyfHXz98ylN1hbwWTK7ANFnGdQM0ZLapfFCsDL5gloPKUQdcMs99CMFyF0KlHbhmqiyCZUIXopJFyZ-RnbZr_QtCSwV-Y6OtQ7h6xa22XLgSHBVpYUfpWEYONsQ2dYIexwoYFyZuQZQw_QIZWBwTF8iIjLzfvjPvgTf-2vsI13DbE0Gz4w_ASiaxkvkXK2XkHXKAQdGG4dU2nVCASSJIljkUWoODCR5nRnYHPUEk62HzhodMUglLA1TDavWSw3febJvxTUxza323xj6lFBiIBpI971luOyUOpqmQpcqIHDDjYM7DlnZ2HgHDlVZMCpmR0YZtr4b1Z5q-_B80fUXuF1HsypxVu2RntVj71-Ru_XM1Wy72yG05lfGu9sido-Px5GwvCjI8TT6fTn7A09mX778AfZRH3w |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQcCF9yNQwEggDt2oWTuxnQNC5VFa9aEeirQ3Yyc2XalKls0uaP8Uv5GZPHZJEb31wGGlaO1EHmfmm3HmRcgrJb3iimWY3c7CmOUutMaL0Gcs40rKXPi8bjYhj47UaJQer5FfXS4MhlV2mFgDdV5m-I18i4kEm31LHr-bfA-xaxR6V7sWGg1b7LvFTziyVW_3PsL7fc3YzqeTD7th21UgzEQkZwDJJuJpnjK4yBPnVRR7xyLDQdTUkMvIcee9N9x6n6QWTBIVM28ikcISJIs5PPcKuQo4LjGETI6WB7whaFveJeYosVUB9ksM8WX4i5NQ9JRf3SPgb03whyo8H6Z5zldbq8Cd2__b5t0ht1pjm2430nGXrLniHrl-2IYT3CfTY4zpyej8LHNT2vqqaN1_ieaLatKMtqVnK2pm1BV5iYk8CzoHLBzQVVwLLT39XOJnGXra9mIZ0NorhsUoKOYVlJOxeUC-XArFD8l6URbuMaGxAvM6T43Fqv6Km9RwYWOw56SBg7eNAjLsuENnbYV2bBRypuuTmhK64SgN3KRrjtIiIJvLeyZNfZILZ79HplvOxNri9R_l9JtuoUpLtElT621m4XCaRJbbVHgeWyy2CNZMQN4gy2pEQFheZtpEDiASa4npbZGmYIeDYR6Qjd5MQK6sP9xxq26Rs9IrVg3Iy-Uw3onRgIUr5zgnlgL99bBljxoZWZLEQYMzGauAyJ709GjujxTj07quukpVJIUMyKCTs9Wy_r2nTy6m4gW5sXtyeKAP9o72n5KbrEaDOIySDbI-m87dM3It-zEbV9PnNZZQ8vWy5e83Czerkw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZbxMxELagoIoX7sJCASMh8UBW3dpeH4_lKCAgisShvlm2d00jVbtRDqT-e2a8m7RbDgnxECmKx8p6MpczM98Q8kyrqLlmAbvbWS5YVefeRZnHwALXSlUyVmnYhBqP9dGRmZzr4k_V7uuUZNfTgChNzXJvVsVOxbXcW4BVVVg8y_AlylxeJlcEDg3C-_rnb5s8Avg_vm6V-e2-gTtKqP2_2uZzzuli4eSF7GlySoc3_v84N8n1PiClB50E3SKX6uY22f7Up9zvkPkE614CXZ2Eek77fA5NM4podbqYdas9POuCuiWtm6rFZpdTugJ7MaJntR-0jfRti39d0ON-XsmIpswRAjZQrL1vZ1N3l3w9fPPl1bu8H9SQB1moJXg5V3BTGQZvqrKOuhCxZoXjYL30PldFzesYo-M-xtJ4iPK0YNEV0jBZKib4Dtlq2qa-T6jQEIJWxnlEvtfcGcelFxDzKAeXU19kZH_9e9nQo5jjMI0Tm24zWtqOmRYYaRMzrczIi82eWYfh8VfqlygGG0rE304ftPPvtldnqzBuMz764OECVxaeeyMjFx4BCcHjZ-Q5CpFFKwGPF1zf7ACHRLwteyCNgVgVgteM7A4oQbvDcHkthra3LgsLXMPB94rD9zzdLONOrJhr6naFNEJJzGkDy-51Urs5Egcvx5TQGVEDeR6cebjSTI8T9rg2ulBSZWS0luqzx_ozTx_8G_kTsj15fWg_vh9_eEiusaQXIi_KXbK1nK_qR-Rq-LGcLuaPk7L_BP5bUpU |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Peptic+ulcer+disease+among+dyspeptic+patients+at+endoscopy+unit%2C+University+of+Gondar+hospital%2C+Northwest+Ethiopia&rft.jtitle=BMC+gastroenterology&rft.au=Belete+Assefa&rft.au=Abilo+Tadesse&rft.au=Zenahebezu+Abay&rft.au=Alula+Abebe&rft.date=2022-04-05&rft.pub=BMC&rft.eissn=1471-230X&rft.volume=22&rft.issue=1&rft.spage=1&rft.epage=7&rft_id=info:doi/10.1186%2Fs12876-022-02245-6&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_758469bfbcb64250b3b96f34b6509284 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-230X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-230X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-230X&client=summon |